Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer-Reference-Cited by-同舟云学术

Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer

Published:2015-12-07 Issue:2 Volume:6 Page:147-153
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Russo Mariangela,Siravegna Giulia,Blaszkowsky Lawrence S.,Corti Giorgio,Crisafulli Giovanni,Ahronian Leanne G.,Mussolin Benedetta,Kwak Eunice L.,Buscarino Michela,Lazzari Luca,Valtorta Emanuele,Truini Mauro,Jessop Nicholas A.,Robinson Hayley E.,Hong Theodore S.,Mino-Kenudson Mari,Di Nicolantonio Federica,Thabet Ashraf,Sartore-Bianchi Andrea,Siena Salvatore,Iafrate A. John,Bardelli Alberto,Corcoran Ryan B.

Funder

NIH/NCI Gastrointestinal Cancer

NIH/NCI

European Community's Seventh Framework Programme

IMI

AIRC 2010 Special Program Molecular Clinical Oncology 5 per mille

AIRC

Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per mille

Ministero dell'Istruzione, dell'Università e della Ricerca, progetto

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 329 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unrevealing the therapeutic benefits of radiotherapy and consolidation immunotherapy using ctDNA-defined tumor clonality in unresectable locally advanced non-small cell lung cancer;Cancer Letters;2024-02

2. Immunosurveillance encounters cancer metabolism;EMBO Reports;2024-01-12

3. Reprogramming and multi-lineage transdifferentiation attenuate the tumorigenicity of colorectal cancer cells;Journal of Biological Chemistry;2024-01

4. Liposomal nanocarriers containing siRNA as small molecule-based drugs to overcome cancer drug resistance;Nanomedicine;2023-11-15

5. Engineering Heterogeneous Tumor Models for Biomedical Applications;Advanced Science;2023-11-09